Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen
43%
Cancer Prognosis
42%
Statin (Protein)
39%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
34%
Cohort Study
21%
Placebo
20%
Cancer Growth
20%
Blindness
20%
Antidiabetic Agent
20%
Cancer Mortality
16%
Prostate Specific Antigen
12%
Cholesterol
10%
Antigen
8%
Glucose
7%
Neoplasm
7%
Incidence
5%
Malignant Neoplasm
5%
Lipid
5%
Recurrent Disease
5%
Medicine and Dentistry
Prostate Cancer
60%
Man
28%
Cohort Analysis
21%
Health Care
20%
Diagnosis
20%
Antidiabetic Agent
20%
Occupational Health
20%
COVID-19
20%
Microarray
20%
Infection Control
20%
Atorvastatin
20%
Androgen Deprivation Therapy
20%
Follow up
15%
Cancer Mortality
14%
Statin
12%
Drug Therapy
8%
Patient
8%
Age
8%
Analysis
8%
Antigen
8%
Neoplasm
7%
Incidence
5%
Randomized Clinical Trial
5%
Blood
5%
Glucose
5%
Adjustment
5%
Recurrent Disease
5%
Biochemistry, Genetics and Molecular Biology
Atorvastatin
60%
Statin
36%
Learning
20%
Randomized Clinical Trial
20%
Drug Megadose
20%
Lipidomics
20%
Microarray
20%
Clinical Study
20%
Classification
12%
Lipidome
10%
Metabolomics
8%
Cancer Cell
8%
Cholesterol
7%
Cholesterol Blood Level
7%
Cancer Mortality
6%
Steroid
5%
Time
5%
Development
5%
Computed Tomography
5%
